S. Wiblin

Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.

B. Cornelissen, A. Banham, M. Cragg, 2017, Cancer research.

Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies

A. Banham, Demin Li, Carol Bentley, 2017, PloS one.

Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A*0201

A. Banham, F. Pezzella, Demin Li, 2021, PloS one.